Hostname: page-component-6766d58669-bkrcr Total loading time: 0 Render date: 2026-05-24T10:47:32.421Z Has data issue: false hasContentIssue false
  • English
  • Français

Value of patient-reported symptoms in the follow up of patients potentially cured of laryngeal carcinoma

Published online by Cambridge University Press:  22 April 2019

J Brandstorp-Boesen ,
U Zätterström ,
J F Evensen  and
M Boysen
J Brandstorp-Boesen
Affiliation:
Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Division of Surgery and Clinical Neuroscience, Oslo University Hospital, Norway
U Zätterström
Affiliation:
Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Division of Surgery and Clinical Neuroscience, Oslo University Hospital, Norway
J F Evensen
Affiliation:
Section for Head and Neck Cancer, Radiumhospitalet, Oslo University Hospital, Norway
M Boysen*
Affiliation:
Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Division of Surgery and Clinical Neuroscience, Oslo University Hospital, Norway
*
Author for correspondence: Dr Morten Boysen, Telthusbakken 39, 0172 Oslo, Norway E-mail: moboysen@online.no
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective

To evaluate the significance of patients’ ability to recognise symptoms that signify recurrence.

Methods

A retrospective analysis was conducted in Norway of demographic, clinical and follow-up data for patients with laryngeal carcinoma considered free of disease following treatment. The study included clinical data from 732 patients with glottic tumours and 249 patients with supraglottic tumours who were considered cured of disease. Data on the site, time and type of recurrence (symptomatic or asymptomatic) were retrieved.

Results

Recurrence was observed in 127 patients with glottic tumours and 71 with supraglottic tumours. A total of 103 glottic recurrences and 53 supraglottic recurrences were symptomatic. For patients with glottic carcinoma, recurrence detection through symptoms was associated with a favourable post-salvage survival rate compared with asymptomatic recurrences (p = 0.003).

Conclusion

A patient's ability to self-detect ‘red flag’ symptoms and self-initiate visits represents a previously ignored prognostic factor, and may rationalise follow up and improve survival.

Keywords

Head and Neck CancerRecurrenceTreatmentFollow-Up CareSurvivalPrognosis

Information

Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 133 , Issue 6 , June 2019 , pp. 508 - 514
Copyright
Copyright © JLO (1984) Limited, 2019 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Footnotes

Dr M Boysen takes responsibility for the integrity of the content of the paper

References

1Posttreatment surveillance of squamous cell carcinoma of the head and neck cancer. In: https://www.uptodate.com/contents/posttreatment-surveillance-of-squamous-cell-carcinoma-of-the-head-and-neck [21 May 2018]Google Scholar
2Boysen, M, Løvdal, O, Tausjö, J, Winther, F. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer 1992;28:426–30Google Scholar
3Agrawal, A, Hammond, TH, Young, GS, Avon, AL, Ozer, E, Schuller, DE et al. Factors affecting long-term survival in patients with recurrent head and neck cancer may help define the role of post-treatment surveillance. Laryngoscope 2009;119:2135–40Google Scholar
4Kernohan, JR, Clark, JR, Gao, K, Ebrahimi, A, Milross, CG. Predicting the prognosis of oral squamous cell carcinoma after first recurrence. Arch Otolaryngol Head Neck Surg 2010;136:1235–9Google Scholar
5Joshi, A, Calman, F, O'Connell, M, Jeannon, JP, Pracy, P, Simo, R. Current trends in the follow-up of head and neck cancer patients in the UK. Clin Oncol (R Coll Radiol) 2010;22:114–18Google Scholar
6Zätteström, U, Boysen, M, Evensen, JF. Significance of self-reported symptoms as part of follow-up routines in patients treated for oral squamous cell carcinoma. Anticancer Res 2014;64:6593–9Google Scholar
7Pagh, A, Vedtofte, T, Duch, C, Lynggaard, CD, Rubek, N, Lonka, M et al. The value of routine follow-up after treatment for head and neck cancer: a national survey from DAHANCA. Acta Oncol 2013;52:277–84Google Scholar
8Leon, X, Quer, M, Diez, S, Orùs, C, Lopez-Pousa, A, Burguès, J. Second neoplasms in patients with head and neck cancer. Head Neck 1999;21:204–10Google Scholar
9Harmer, MH, ed.; UICC. TNM Classification of Malignant Tumours, 3rd edn. Geneva: UICC, 1982Google Scholar
10Sobin, LH, Wittekind, CH, eds.; UICC. TNM Classification of Malignant Tumours, 6th edn. New York: Wiley-Liss, 2002Google Scholar
11Vermund, H, Boysen, M, Brandenburg, JH, Evensen, J, Jacobsen, AB, Kaalhus, O et al. Primary irradiation, surgery or combined therapy in squamous cell carcinoma of the larynx: a comparison of treatment results from two centers. Acta Oncol 1990;29:489–97Google Scholar
12Vermund, H, Boysen, M, Evensen, J. Recurrence after different primary treatment for cancer of the supraglottic larynx. Acta Oncol 1998;37:167–73Google Scholar
13Mahler, V, Boysen, M, Bröndbo, K. Radiotherapy or CO2 laser surgery in the treatment of T1a glottic carcinoma. Eur Arch Otorhinolaryngol 2010;267:743–50Google Scholar
14Warren, S, Gates, O. Multiple primary malignant tumors: a survey of the literature and statistical study. Am J Cancer 1932;16:1358–414Google Scholar
15Roman, BR, Goldenberg, D, Givi, B. AHNS Series – Do you know your guidelines? Guideline recommended follow-up and surveillance of head and neck cancer survivors. Head Neck 2016;38:168–74Google Scholar
16Simo, R, Homer, PC, Mackenzie, K, Paleri, V, Roland, N. Follow-up after treatment for head and neck cancer. J Laryngol Otol 2016;130(suppl 2):S208–11Google Scholar
17Grégoire, V, Lefebvre, JL, Licitra, L, Felip, E; EHNS-ESMO-ESTRO Guidelines Working Group. Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21(suppl 5):v184–6Google Scholar
18Morton, R, Hay, KD, Macann, A. On completion of curative treatment of head and neck cancer: why follow-up? Curr Opin Otolaryngol Head Neck Surg 2004;2:142–6Google Scholar
19Manikantan, K, Khode, S, Dwivedi, RC, Palav, R, Nutting, CM, Rhys-Evans, P et al. Making sense of post-treatment surveillance in head and neck cancer: when and what of follow-up. Cancer Treat Rev 2009;35:744–53Google Scholar
20de Visscher, AV, Manni, JJ. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx and oral cavity. Does it make sense? Arch Otolaryngol Head Neck Surg 1994;120:934–9Google Scholar
21Flynn, CJ, Khaouam, N, Gardner, S, Higgins, D, Enepekeds, D, Balogh, J et al. The value of periodic follow-up in the detection of recurrences after radical treatment in locally advanced head and neck cancer. Clin Oncol 2010;22:868–73Google Scholar
22Kumar, R, Putnam, G, Robson, AK. Can head and neck cancer patients be discharged after three years? J Laryngol Otol 2013;127:991–6Google Scholar
23Stimpson, P, Batt, M, Vallance, N. Head and neck recurrence: a prospective analysis of 401 follow-up visits to an Australian cancer centre. Clin Otolaryngol 2014;39:289–315Google Scholar
24Digonnet, A, Hamoir, M, Andry, G, Haigentz, M Jr, Takes, RP, Silver, CE et al. Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2013;270:1569–80Google Scholar
25Ritoe, SC, Krabbe, PF, Kaanders, JA, van den Hoogen, FJ, Verbek, AL, Marres, HA. Value of routine follow-up in patients cured of laryngeal carcinoma. Cancer 2004;101:1382–9Google Scholar
26Haas, I, Hauser, U, Ganzer, U. The dilemma of follow-up in head and neck cancer patients. Eur Arch Otorhinolaryngol 2001;258:177–83Google Scholar
27Nordgren, M, Abendstein, H, Jannert, M, Boysen, M, Ahlner-Elmqvist, M, Silander, E et al. Health-related quality of life five years after diagnosis of laryngeal carcinoma. Int J Radiat Oncol Biol Phys 2003;56:133–43Google Scholar
28Bradley, PJ, Bradley, PT. Searching for metachronous tumours in patients with head and neck cancer: the ideal protocol! Curr Opin Otolaryngol Head Neck Surg 2010;18:124–33Google Scholar
29Lewis, RA, Neal, RD, Williams, NH, France, B, Hendry, M, Russel, D. Nurse-led vs. conventional physician-led follow-up for patients with cancer: systematic review. J Adv Nurs 2009;64:706–23Google Scholar
30Kimman, ML, Bloebaum, MM, Dirksen, CD, Houben, RM, Lambin, P, Boersma, LJ. Patient satisfaction with nurse-led telephone follow-up after curative treatment for breast cancer. BMC Cancer 2010;10:174–83Google Scholar
31de Leeuw, J. Nurse-led Follow-up Care in Head and Neck Cancer Patients. Nijmegen: Radboud University, 2013Google Scholar
32Trinidade, A, Kothari, P, Andreou, Z, Hewitt, RJ, O'Flynn, P. Follow-up in head and neck cancer: patients’ perspective. Int J Health Care Qual Assur 2012;25:145–9Google Scholar
33Kothari, P, Trinidade, A, Hewitt, RJ, Sing, A, O'Flynn, P. The follow-up of patients with head and neck cancer: an analysis of 1,039 patients. Eur Arch Otorhinolaryngol 2010;268:1191–200Google Scholar
34Lester, SE, Wight, RG. “When will I see you again?” Using local recurrence data to develop a regimen for routine surveillance in post-treatment head and neck cancer patients. Clin Otolaryngol 2009;34:546–51Google Scholar
35Schwartz, DL, Rajencran, J, Yuch, B, Coltrera, MC. FDG-PET prediction of head and neck squamous cell carcinoma cancer outcomes. Arch Otolaryngol Head Neck Surg 2004;130:1361–7Google Scholar
36Goerres, GW, Schmid, DT, Bandhauer, F, Hugenin, PU, von Schulthess, G, Schmid, S et al. Positron emission tomography in the early follow-up of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2004;130:105–9Google Scholar
37Zbären, P, de Bree, R, Takes, P, Rinaldo, A, Ferlito, A. Which is the most reliable diagnostic modality for detecting locally residual or recurrent laryngeal squamous cell carcinoma after (chemo)radiotherapy? Eur Arch Otorhinolaryngol 2013;270:2787–91Google Scholar
38Screening for lung cancer. In: https://www.uptodate.com/contents/screening-for-lung-cancer?search=Deffenbach%20ME,%20Humprey%20L,%20Elmore%20JG,%20Jett%20RL,%20Vora%20SR.%20Screening%20for%20lung%20cancer%20%20&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2 [21 May 2018]Google Scholar
39Geurts, TW, Balm, AJ, van Velthuisen, ML, van Tinteren, H, Burgers, JA, van Zandwijk, N. Survival after surgical resection of pulmonary metastasis and second primary squamous cell carcinomas in head and neck cancer patients. Head Neck 2009;31:220–6Google Scholar
40Steinkamp, HJ, Wissgott, C, Rademaker, J, Felix, R. Current status of power Doppler and color Doppler sonography in the differential diagnosis of lymph node lesions. Eur Radiol 2002;12:1785–93Google Scholar
41Wolfsenberger, M. Consumption and value of regular after care by patients with squamous cell carcinomas of the larynx, mouth cavity and pharynx [in German]. HNO 1988;36:28–33Google Scholar
42Virgo, KS, Paniello, RC, Johnson, FE. Costs of posttreatment surveillance for patients with upper aerodigestive tract cancer. Arch Otolaryngol Head Neck Surg 1998;124:564–72Google Scholar